Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 504-512

  Leadbetter, Elizabeth A ^a,b   Bourque, Cheryl R ^a   Devaux, Brigitte ^a,c   Olson, Carl D ^a   Sunshine, Geoffrey H ^a,d   Hirani, Shirish ^a,e   Wallner, Barbara P ^a,f   Smilek, Dawn E ^a   Happ, Mary Pat ^a  

^a ImmuLogic Pharmaceutical Corporation   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

^d Health Effects Institute   (United States)

^e Dyax Corp   (United States)

^f Point Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DOWN REGULATION; FEMALE; IMMUNOREACTIVITY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MOLECULAR RECOGNITION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0031802996     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Traugott, U. 1984. Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions. Springer Semin. Immunopathol. 8:71.
2. Martin, R., H. F. McFarland, and D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
3. Johnson, D., D. A. Hafler, R. J. Fallis, M. B. Lees, R. O Brady, R. H. Quarles, and H. L. Weiner. 1986. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J. Neuroimmunol. 13:99.
4. Link, H., J. Sun, Z. Wang, Z. Xu, A. Löve, S. Fredrikson, and T. Olsson. 1992. Virus-reactive and autoreactive T-cells are accumulated in cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:63.
5. Chou, Y. K., D. N. Bourdette, H. Offner, R. Whitham, R. Wang, G. A. Hashim, and A. A. Vandenbark. 1992. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:105.
6. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973.
7. Sun, J., H. Link, T. Olsson, B.-G. Xiao, G. Andersson, H.-P. Ekre, C. Linington, and P. Diener. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490.
8. Kerlero de Rosbo, N., R. Milo, M. B. Lees, D. Burger, C. C. A. Bernard, and A. Ben-Nun. 1993. Reactivity to myelin antigens in multiple sclerosis: peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602.
9. Oksenberg, J. R., M. A. Panzara, A. B. Begovich, D. Mitchell, H. A. Erlich, R. S. Murray, R. Shimonkevitz, M. Sherritt, J. Rothbard, C. C. A. Bernard, and L. Steinman. 1993. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68.
10. Tuohy, V. K., R. A. Sobel, and M. B. Lees. 1988. Myelin proteolipid protein- induced experimental allergic encephalomyelitis. J. Immunol. 140:1868.
11. Fritz, R. B., C.-H. Chou, and D. E. McFarlin. 1983. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130:1024.
12. Amor, S., M. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J.-M. Mattieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349.
13. Johns, T. G., N. Kerlero de Rosbo, K. K. Menon, S. Abo, M. F. Gonzales, and C. C. A. Bernard. 1995. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:5536.
14. Pettinelli, C. B., R. B. Fritz, C.-H. Jen Chou, and D. E. McFarlin. 1982. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J. Immunol. 129:1209.
15. Smilek, D. E., D. C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman, and H. O. McDevitt. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:9633.
16. Gaur, A., B. Wiers, A. Liu, J. Rothbard, and C. G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
17. Metzler, B., and D. C. Wraith. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1159.
18. Franco, A., S. Southwood, T. Arrhenius, V. K. Kuchroo, H. M. Grey, A. Sette, and G. Y. Ishioka. 1994. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24:940.
19. Liu, G. L., and D. C. Wraith. 1995. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice: implications for autoimmunity. Int. Immunol. 7:1255.
20. Nicholson, L. B., A. Murtaza, B. P. Hafler, A. Sette, and V. K. Kuchroo. 1997. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA 94:9279.
21. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Ulz, N. Karin, D. Mitchell, T. Veromaa, A. Walsman, A. Gaur, P. Conlon, N. Ling, D. C. Wraith, A. O'Garra, C. G. Fathman, and L. Steinman. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
22. Samson, M., and D. E. Smilek. 1995. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long lived peptide-MHC complexes. J. Immunol. 155:2737.
23. Devaux, B., F. Enderlin, B. Wallner, and D. E. Smilek. 1997. Induction of EAE in mice with recombinant human MOG and treatment of EAE with a MOG peptide. J. Neuroimmunol. 75:169.
24. Kennedy, M. K., L. Tan, M. C. Dal Canto, V. K. Tuohy, Z. Lu, J. L. Trotter, and S. D. Miller. 1990. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J. Immunol. 144:909.
25. Al-Sabbagh, A., A. Miller, L. M. B. Santos, and H. L. Weiner. 1994. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental auto-immune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24:2104.
26. Falcone, M., and B. R. Bloom. 1997. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:901.
27. Hoyne, G. F., A. G. Jarnicki, W. R. Thomas, and J. R. Lamb. 1997. Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression. Int. Immunol. 9:1165.
28. Davies, J. D., L. Y. W. Leong, A. Mellor, S. P. Cobbold, and H. Waldmann. 1996. T cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156:3602.
29. Elliott, E. A., H. I. McFarland, S. H. Nye, R. Cofiell, T. M. Wilson, J. A. Wilkins, S. P. Squinto, L. A. Matis, and J. P. Mueller. 1996. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98:1602.
30. Smith, M. E. 1969. An in vitro system for the study of myelin synthesis. J. Neurochem. 16:83.
31. Kerlero de Rosbo, N., I. Mendel, and A. Ben-Nun. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:985.
32. 1 hybrid mice. J. Immunol. 134:3574.
33. Pham-Dinh, D., M. Mattei, J. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. Fischer Lindahl, and A. Dautigny. 1993. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90:7990.
34. Hilton, A. A., A. J. Slavin, D. J. Hilton, and C. C. A. Bernard. 1995. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J. Neurochem. 65:309.
35. Zamvil, S. S., D. J. Mitchell, A. C. Moore, K. Kitamura, L. Steinman, and J. B. Rothbard. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258.
36. Zamvil, S. S., P. A. Nelson, D. J. Mitchell, R. L. Knobler, R. B. Fritz, and L. Steinman. 1985. Encephalitogenic T cell clones specific for myelin basic protein: an unusual bias in antigen recognition. J. Exp. Med. 162:2107.
37. Kono, D. W., J. L. Urban, S. J. Horvath, D. G. Ando, R. A. Saavedra, and L. Hood. 1988. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J. Exp. Med. 168:213.
38. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016.
39. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin oligodendrocyte glycoprotein. Am. J. Pathol. 130:443.
40. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
41. Gautam, A. M., C. B. Lock, D. E. Smilek, C. I. Pearson, L. Steinman, and H. O. McDevitt. 1994. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity. Proc. Natl. Acad. Sci., USA 91:767.
42. Fairchild, P. J., R. Wildgoose, E. Atherton, S. Webb, and D. C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151.
43. u, which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 2:181.
44. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 147:2155.
45. Marusic, S., and S. Tonegawa. 1997. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide. J. Exp. Med. 186:507.
46. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.
47. Genain, C. P., K. Abel, N. Belmar, F. Villinger, D. P. Rosenberg, C. Linington, C. S. Raine, and S. L. Hauser. 1996. Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054.